A novel therapy for myasthenia gravis by reducing the endocytosis of acetylcholine receptors

Ann N Y Acad Sci. 1993 Jun 21:681:298-302. doi: 10.1111/j.1749-6632.1993.tb22900.x.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Down-Regulation / drug effects
  • Endocytosis / drug effects
  • Female
  • Immunization
  • Immunization, Passive
  • Mice
  • Myasthenia Gravis / drug therapy*
  • Rats
  • Rats, Inbred Lew
  • Receptors, Nicotinic / metabolism*
  • Tubercidin / pharmacology

Substances

  • Receptors, Nicotinic
  • 3-deazaadenosine
  • Tubercidin